Search

ProQR presentation and panel session at the Oligonucleotide and Precision Therapeutics (OPT) Congress

On March 29, 2023 ProQR will host a virtual R&D event to showcase its proprietary Axiomer RNA-editing technology platform. ProQR will also announce initial pipeline targets for internal development.

With the announcement of the expansion of ProQR and Lilly's partnership, ProQR Management is hosting a conference call.

ProQR to present at the TIDES Europe conference on oligonucleotide and peptide therapeutics in Vienna, Austria and online.

ProQR is participating in the Stifel 2022 Healthcare Conference.

ProQR to Focus Exclusively on Axiomer RNA-editing Technology and Partner Ophthalmology Programs - Management Call

ProQR's participation in the Life Sci 2nd Annual Genetic Medicines Symposium

ProQR's 2022 Annual General Meeting (AGM) of Shareholders will take place on Thursday, June 30, 2022 at 14:00 CET (08:00am EDT) via videoconference.

ProQR to present at the Retinal Cell and Gene Therapy Innovation Summit.

Company management will participate in the Kempen Life Sciences Conference on April 20.